Loading asset research
Prenetics Global Limited Class A Ordinary Share
PRENasdaq · USD · StocksQuote as of · Exchange session not verified$23.47
-0.80%
Today
PRE
Loading 1D prices…
Market cap
$393.8M
Volume
143.9K
52w high
$27.2452w low
$9.28Company profile
Prenetics Global Limited Class A Ordinary Share
Prenetics Global Limited operates as a consumer health sciences company in the United States and Hong Kong. The company focuses on advancing human health and longevity through science-backed products under the IM8 brand. It also operates a consumer genetic testing brand in CircleDNA leveraging sequencing technology to deliver personalized reports across various categories. The company was founded in 2014 and is headquartered in Quarry Bay, Hong Kong.
Sector
Health Care
Industry
Pharmaceutical Preparations
Exchange
Nasdaq
Display currency
USD
Location
Quarry Bay, Hong Kong, United States
Employees
98
Fiscal year end
1231
CIK
1876431
Session & valuation
Open$23.78
Previous close$23.66
Day high$23.90
Day low$22.95
30-day avg. volume235.7K
Outstanding shares16.9M
Diluted EPS-$4.15
Latest annual period
P/E (trailing)-5.66
P/E (forward)-8.77
Price / book4.36
Beta0.31
Dividend yield—
Deterministic peer set
Companies with SEC SIC 2834
Exact regulatory industry matches, ranked by nearest market capitalization.
| Company | Market cap | Revenue | Net margin | Diluted EPS | Today | Consensus |
|---|---|---|---|---|---|---|
| GALTGalectin Therapeutics Inc. Common Stock | $394.3M | $0.00 | — | -$0.48 | +0.38% | Buy |
| BBOTBridgeBio Oncology Therapeutics Inc. Common Stock | $396.9M | $0.00 | — | -$4.30 | -10.87% | Buy |
| BIOABioAge Labs Inc. Common Stock | $389.7M | $9M | -896.11% | -$2.24 | -1.85% | Buy |
| TTRXTurn Therapeutics Inc. Common Stock | $385.4M | $0.00 | — | -$0.12 | -5.16% | Buy |
| EVMNEvommune Inc. Common Stock | $382.5M | $13M | -529.77% | -$11.22 | -0.19% | Buy |